XPC and hepatocellular carcinoma: Lys939Gln allele differed in HCC risk, with risk of XPC-GG > XPC-LG > XPC-LL.Heterozygous XPC 939LG and/or homozygous XPC 939GG, compared to homozygous XPC 939LL was associated with shorter overall survival